ANGO vs JPM · rev $292.5M vs P/E 14, rev $182.45B
AngioDynamics Inc (ANGO) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported JPM revenue for 2025-12-31 was $182.45B. Net income was $57.05B. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
ANGO currently screens at market cap $378.5M. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the ANGO and JPM stock pages for the full models.
Not investment advice.